About
Stimdia Medical is a Minnesota-based medical technology company founded in 2015, emerging from the University of Minnesota. The company focuses on developing solutions to expedite ventilator weaning and improve patient outcomes, particularly for those experiencing ventilator-induced diaphragmatic dysfunction (VIDD). Stimdia Medical has garnered significant investment from various sources, including Solas BioVentures and Draper Triangle Ventures. The company's primary product is the pdSTIM™ System, a neurostimulation therapy designed for mechanically ventilated adults with diaphragmatic dysfunction. This minimally invasive system uses temporary pacing leads to stimulate the phrenic nerves, helping to recondition the diaphragm muscle and support independent breathing. The pdSTIM System is intended for patients who have been on mechanical ventilation for over 96 hours and have struggled with weaning attempts. Currently, it is an investigational device undergoing FDA-approved pivotal trials. Stimdia Medical's leadership team possesses extensive experience in medical device development and clinical research, emphasizing a commitment to enhancing patient care and quality of life in respiratory care.
Technologies
Keywords
Company Information
-
Employees 15
-
Founded 2015
-
Annual Revenue $4000000
-
Total Funding $19180588
Location
3800 American Blvd W, Minneapolis, Minnesota, United States, 55431-4407